Seems like a fairly easy decision then with respect to buying the pref shares over the ordinaries.Thanks for clearing that up. Cheers
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025